Analyze Diet

Evaluation of coagulation and fibrinolysis during the prodromal stages of carbohydrate-induced acute laminitis in horses.

Abstract: The balance of coagulation and fibrinolysis was studied in 15 horses during the prodromal stages of acute laminitis induced by carbohydrate overload. Progression of the disease was stopped 12 to 24 hours before the expected onset of lameness in trial 1 (8 horses) and at the onset of lameness in trial 2 (7 horses). The end points in each trial were identified by specific changes in blood pressures (trial 1) and by changes in pulse, rectal temperature, and arterial pressure (trial 2) that were anticipated on the basis of original description of the experimental model. Blood samples for hemostasis evaluation were collected before and after carbohydrate overload in trial 1 and after carbohydrate overload in trial 2. Significant changes were not detected in platelet count, mean platelet volume, prothrombin time, activated partial thromboplastin time, fibrinogen concentration, plasminogen concentration, alpha-2-antiplasmin, antithrombin III, protein C, thromboxane B2, or fibrin(ogen) degradation product concentration. We concluded that an imbalance in coagulation and fibrinolysis is not pathogenic in the onset of experimentally induced equine acute laminitis. Because several test methods used to evaluate hemostasis in these horses were new, reference values for 34 healthy adult horses were established.
Publication Date: 1990-12-01 PubMed ID: 2085221
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates the role of coagulation and fibrinolysis, major processes involved in blood clotting and clot removal respectively, during the initial stages of acute laminitis in horses. Laminitis is a serious disease affecting the hooves of horses, and this research, which involved 15 horses, found that imbalances in coagulation and fibrinolysis do not cause the onset of this condition.

Experiment Setup and Procedure

  • The study made use of a sample size of 15 horses, which were subjected to carbohydrate overload to induce acute laminitis – a painful and potentially crippling disorder that can affect the hooves of horses.
  • In order to monitor the progression of the disease, it was ceased 12 to 24 hours prior to when lameness was expected to set in the first trial involving 8 horses; and at the point of lameness in the second trial involving the remaining 7 horses.
  • The stopping points for each trial were determined based on specific changes in blood pressures (in the first trial) and changes in pulse, rectal temperature, and arterial pressure (in the second trial) according to the parameters set by the original experimental model.
  • Blood samples were drawn both before and after the carbohydrate overload in the first trial and only after the carbohydrate overload in the second trial. These were used for the assessment of hemostasis, which is the process of blood clot formation and disintegration.

Findings and Conclusions

  • Despite these induced conditions, the researchers did not detect any significant changes in various parameters. These include platelet count, mean platelet volume, prothrombin time, activated partial thromboplastin time, fibrinogen concentration, plasminogen concentration, alpha-2-antiplasmin, antithrombin III, protein C, thromboxane B2, and fibrin(ogen) degradation product concentration.
  • The paper, therefore, comes to the conclusion that there is no correlation between imbalances of coagulation and fibrinolysis and the onset of acute laminitis in horses. Essentially, disorders in the clotting and clot removal systems of horses’ blood do not appear to play a role in triggering equine acute laminitis.
  • However, it’s worth noting that several new test methods were employed in the evaluation of hemostasis in the horses under study. As a result, the researchers also established reference values for these measures from 34 healthy adult horses.

Cite This Article

APA
Prasse KW, Allen D, Moore JN, Duncan A. (1990). Evaluation of coagulation and fibrinolysis during the prodromal stages of carbohydrate-induced acute laminitis in horses. Am J Vet Res, 51(12), 1950-1955.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 51
Issue: 12
Pages: 1950-1955

Researcher Affiliations

Prasse, K W
  • Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens 30602.
Allen, D
    Moore, J N
      Duncan, A

        MeSH Terms

        • Animals
        • Blood Coagulation / drug effects
        • Blood Pressure / drug effects
        • Carbohydrates / administration & dosage
        • Carbohydrates / adverse effects
        • Central Venous Pressure / drug effects
        • Fibrinolysis / drug effects
        • Foot Diseases / blood
        • Foot Diseases / etiology
        • Foot Diseases / veterinary
        • Hemodynamics / drug effects
        • Hemostasis / drug effects
        • Horse Diseases / blood
        • Horse Diseases / etiology
        • Horses
        • Lameness, Animal / blood
        • Lameness, Animal / etiology
        • Time Factors

        Citations

        This article has been cited 2 times.
        1. Suagee JK, Corl BA, Geor RJ. A Potential Role for Pro-Inflammatory Cytokines in the Development of Insulin Resistance in Horses.. Animals (Basel) 2012 May 2;2(2):243-60.
          doi: 10.3390/ani2020243pubmed: 26486919google scholar: lookup
        2. Johnstone IB, Martin CA. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.. Can J Vet Res 2000 Apr;64(2):117-22.
          pubmed: 10805251